Eosinophilic esophagitis

Allergy Asthma Clin Immunol. 2024 Dec 19;20(Suppl 3):72. doi: 10.1186/s13223-024-00929-0.

Abstract

Eosinophilic esophagitis (EoE) is an atopic condition of the esophagus that has become increasingly recognized. Diagnosis of the disorder is dependent on the patient's clinical manifestations and must be confirmed by histologic findings on esophageal mucosal biopsies. The epidemiology, pathophysiology, diagnosis, treatment, and prognosis of EoE are discussed in this review.

• EoE is an atopic condition of the esophagus that has become increasingly recognized. • Endoscopic mucosal biopsy revealing ≥ 15 eosinophils/HPF in one or more specimens remains the most important diagnostic test for EoE, and is mandatory for diagnosis. • Patients with EoE should be referred to an allergist to help optimize treatment, and manage concurrent atopic conditions. • Skin or specific IgE blood testing for foods is not indicated for the identification of EoE triggers, as this is not an IgE-mediated disease. • A trial of PPI is no longer a diagnostic criterion for EoE. To simplify, there is no longer a need to consider the term PPI-REE clinically. • The elemental diet and empiric dietary restrictions are associated with high rates of clinical and histologic improvement in patients with EoE. • Pharmacologic management options include PPI, topical corticosteroids delivered to the esophagus or biologics. • Esophageal endoscopic dilation is most commonly used in adults with established esophageal strictures. • While it is unclear whether OIT causes or unmasks EoE, continuing or initiating OIT as long as EoE is well controlled could be considered. More research is needed.

Keywords: Diagnosis; Elemental diet; Empiric dietary restrictions; Endoscopic dilation; Eosinophilic esophagitis; Prognosis; Proton pump inhibitors; Treatment.

Publication types

  • Review